loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 21726 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ALPRAZOLAM (4)

filter

01 UCB INC (4)

filter

01 TABLET, ORALLY DISINTEGRATING;ORAL (4)

filter

01 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

02 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

03 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

04 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

filter

01 USA (4)

URL Supplier Web Content
TABLET, ORALLY DISINTE...
0.25MG **Federal Regis...
NIRAVAM
USA
21726
2005-01-19
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, ORALLY DISINTE...
2MG **Federal Register...
NIRAVAM
USA
21726
2005-01-19
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, ORALLY DISINTE...
0.5MG **Federal Regist...
NIRAVAM
USA
21726
2005-01-19
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, ORALLY DISINTE...
1MG **Federal Register...
NIRAVAM
USA
21726
2005-01-19
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 21726

Looking for CTD TGA MCC DOSSIER APPLICATION 21726 4

19

UCB Pharma S.A, based in Belgium, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is ALPRAZOLAM, with a corresponding application number 21726 and regulatory information .

proudly manufactured in the

approval since 2005-01-19

UCB Pharma S.A's NIRAVAM TABLET, ORALLY DISINTEGRATING;ORAL, medication with 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ALPRAZOLAM.

18

UCB Pharma S.A, based in Belgium, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is ALPRAZOLAM, with a corresponding application number 21726 and regulatory information .

proudly manufactured in the

approval since 2005-01-19

UCB Pharma S.A's NIRAVAM TABLET, ORALLY DISINTEGRATING;ORAL, medication with 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ALPRAZOLAM.

17

UCB Pharma S.A, based in Belgium, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is ALPRAZOLAM, with a corresponding application number 21726 and regulatory information .

proudly manufactured in the

approval since 2005-01-19

UCB Pharma S.A's NIRAVAM TABLET, ORALLY DISINTEGRATING;ORAL, medication with 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ALPRAZOLAM.

16

UCB Pharma S.A, based in Belgium, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is ALPRAZOLAM, with a corresponding application number 21726 and regulatory information .

proudly manufactured in the

approval since 2005-01-19

UCB Pharma S.A's NIRAVAM TABLET, ORALLY DISINTEGRATING;ORAL, medication with 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ALPRAZOLAM.

Post Enquiry
POST ENQUIRY